JPMorgan Chase & Co. Has $84.79 Million Stake in Nu Skin Enterprises, Inc. (NUS)

JPMorgan Chase & Co. decreased its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 8.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,349,319 shares of the company’s stock after selling 124,768 shares during the quarter. JPMorgan Chase & Co. owned 2.55% of Nu Skin Enterprises worth $84,791,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of NUS. Creative Planning grew its holdings in shares of Nu Skin Enterprises by 38.5% in the 1st quarter. Creative Planning now owns 1,800 shares of the company’s stock worth $100,000 after purchasing an additional 500 shares during the last quarter. US Bancorp DE grew its holdings in shares of Nu Skin Enterprises by 3.3% in the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after purchasing an additional 65 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Nu Skin Enterprises by 23.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock worth $139,000 after purchasing an additional 468 shares during the last quarter. Independent Portfolio Consultants Inc. grew its holdings in shares of Nu Skin Enterprises by 14.9% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 2,730 shares of the company’s stock worth $172,000 after purchasing an additional 355 shares during the last quarter. Finally, CENTRAL TRUST Co bought a new stake in shares of Nu Skin Enterprises in the 2nd quarter worth about $187,000. 79.25% of the stock is currently owned by institutional investors and hedge funds.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 7,500 shares of the business’s stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the completion of the transaction, the general counsel now owns 52,230 shares of the company’s stock, valued at $3,179,762.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, President Ryan S. Napierski sold 8,000 shares of the business’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total value of $520,000.00. Following the transaction, the president now directly owns 68,170 shares of the company’s stock, valued at approximately $4,431,050. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,750 shares of company stock valued at $1,495,690. Insiders own 5.20% of the company’s stock.

WARNING: This report was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://sportsperspectives.com/2017/09/10/jpmorgan-chase-co-has-84-79-million-stake-in-nu-skin-enterprises-inc-nus.html.

NUS has been the topic of several analyst reports. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Deutsche Bank AG upped their target price on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the stock a “buy” rating in a report on Wednesday, June 21st. Pivotal Research reaffirmed a “buy” rating and issued a $80.00 target price (up previously from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Bank of America Corporation increased their price objective on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $62.88.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) opened at 61.89 on Friday. Nu Skin Enterprises, Inc. has a one year low of $46.35 and a one year high of $66.04. The firm’s 50-day moving average is $60.69 and its 200-day moving average is $57.33. The company has a market cap of $3.28 billion, a price-to-earnings ratio of 20.70 and a beta of 1.37.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.08. The firm had revenue of $550.10 million during the quarter, compared to the consensus estimate of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.79 earnings per share. Analysts expect that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.33%. The ex-dividend date is Wednesday, August 23rd. Nu Skin Enterprises’s payout ratio is 48.81%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply